CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
HYPMED aims to enhance breast cancer diagnosis through a novel imaging tool that integrates a digital PET detector with MRI technology. This system will provide high-resolution imaging and enable targeted biopsies, improving non-invasive cancer characterization and treatment guidance.
Breast cancer represents a leading cause of cancer death in women and a major socio-economic issue.
With currently available methods, early diagnosis frequently fails.
Moreover, beyond mere detection, there is an ever-increasing need for improved non-invasive characterisation of cancer.
Targeted therapies require an in-depth analysis of cancer to select and guide appropriate treatment.
Both, PET and MRI can provide molecular and functional information that may be of pivotal importance for tailor…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, Aachen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
MEDIZINISCHE UNIVERSITAET WIEN
Austria, Wien
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Delft
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
